Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer

Liu-Sheng Peng1, Jin-Yu Zhang1, Yong-Sheng Teng1

  • 1National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.

Insights

Natural killer (NK) cells are crucial for fighting gastric cancer but are decreased and functionally impaired within tumors. Tumor-associated monocytes/macrophages suppress NK-cell activity, suggesting a therapeutic target.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Natural killer (NK) cells are vital for anti-tumor immunity in human cancers.
  • The role and regulation of NK cells in gastric cancer are not well understood.
  • NK cell dysfunction is implicated in tumor immune evasion.

Purpose of the Study:

  • To investigate the characteristics and function of NK cells in gastric cancer.
  • To determine the impact of tumor microenvironment on NK cell activity.
  • To explore potential therapeutic strategies targeting NK cells in gastric cancer.

Main Methods:

  • Quantification of tumor-infiltrating NK cells and analysis of their receptor expression.
  • Assessment of NK cell effector functions (IFNγ, TNFα, Ki-67 expression).
  • Co-culture experiments with tumor-associated monocytes/macrophages and blockade of TGFβ1.

Main Results:

  • Gastric tumors showed decreased percentages of NK cells, correlating with poor survival.
  • Tumor-infiltrating NK cells exhibited impaired effector functions despite normal receptor expression.
  • Monocytes/macrophages in close proximity to NK cells suppressed their function, partially mediated by TGFβ1.

Conclusions:

  • NK cell function is significantly impaired in the gastric tumor microenvironment by associated monocytes/macrophages.
  • Restoring NK cell function represents a promising therapeutic avenue to overcome immune escape in gastric cancer.
  • Targeting monocyte/macrophage-mediated suppression could enhance anti-tumor immunity.

Related Concept Videos